Introduction: Children and adolescents with diabetes are increasingly using technological devices to maintain normoglycemia. However, skin problems associated with these devices are becoming a significant issue. This study aimed to investigate prevalence of skin issues in children and adolescents with diabetes globally and identify important factors associated with these skin problems. Methods: This multinational study involved 22 pediatric diabetes centers. Over a 4-week period, pseud anonymized data were collected on children and adolescents using diabetes devices, including demographic factors, visual skin problems, type of devices and products being used. Univariate logistic regression was applied to identify associations with skin problems. Results: A total of 1,719 children and adolescents were included. Skin problems were present in 52% of pump users compared to 30% of sensor users. Eczema was found in 9% of participants at both insulin pump and glucose sensor sites, whereas scars, wounds, and lipodystrophies were significantly more frequent at insulin pump sites than at glucose sensor sites. Both xerosis cutis and keratosis pilaris were strongly associated with almost all types of skin problems, increasing the risk 2 to fivefold. Conclusion: Skin problems are a serious concern that limits the use of diabetes devices in children and adolescents, consequently increasing risk for long-term complications. This study highlights the extent of the problem in a real-world setting of unselected participants despite the use of preventive strategies. Consequently, the development of more skin-friendly devices is needed to ensure that all children and adolescents with diabetes can effectively use these devices in the long term.

1.
American Diabetes Association Professional Practice Committee
,
Draznin
B
,
Aroda
VR
,
Bakris
G
,
Benson
G
,
Brown
FM
.
7. Diabetes technology: standards of medical care in diabetes-2022
.
Diabetes Care
.
2022
;
45
(
Suppl 1
):
S97
112
.
2.
Nørgaard
K
,
Ranjan
AG
,
Laugesen
C
,
Tidemand
KG
,
Green
A
,
Selmer
C
, et al
.
Glucose monitoring metrics in individuals with type 1 diabetes using different treatment modalities: a real-world observational study
.
Diabetes Care
.
2023
:
dc231137
.
3.
Michou
P
,
Gkiourtzis
N
,
Christoforidis
A
,
Kotanidou
EP
,
Galli-Tsinopoulou
A
.
The efficacy of automated insulin delivery systems in children and adolescents with type 1 diabetes Mellitus: a systematic review and meta-analysis of randomized controlled trials
.
Diabetes Res Clin Pract
.
2023
;
199
:
110678
.
4.
Criego
A
,
Carlson
AL
,
Brown
S
,
Forlenza
GP
,
Bode
B
,
Levy
C
, et al
.
Two years with a tubeless AID system: a single-arm multicenter trial in children, adolescents, and adults with type 1 diabetes
.
Diabetes Technol Ther [Internet]
.
2023
. Available at: https://www.liebertpub.com/doi/abs/10.1089/dia.2023.0364
5.
Ware
J
,
Allen
JM
,
Boughton
CK
,
Wilinska
ME
,
Hartnell
S
,
Thankamony
A
, et al
.
Randomized trial of closed-loop control in very young children with type 1 diabetes
.
N Engl J Med
.
2022
;
386
(
3
):
209
19
.
6.
Hood
KK
,
Laffel
LM
,
Danne
T
,
Nimri
R
,
Weinzimer
SA
,
Sibayan
J
, et al
.
Lived experience of advanced hybrid closed-loop versus hybrid closed-loop: patient-reported outcomes and perspectives
.
Diabetes Technol Ther
.
2021
;
23
(
12
):
857
61
.
7.
Wadwa
RP
,
Reed
ZW
,
Buckingham
BA
,
DeBoer
MD
,
Ekhlaspour
L
,
Forlenza
GP
, et al
.
Trial of hybrid closed-loop control in young children with type 1 diabetes
.
N Engl J Med
.
2023
;
388
(
11
):
991
1001
.
8.
Craig
ME
,
Codner
E
,
Mahmud
FH
,
Marcovecchio
ML
,
DiMeglio
LA
,
Priyambada
L
, et al
.
ISPAD clinical practice consensus guidelines 2022: editorial
.
Pediatr Diabetes
.
2022
;
23
(
8
):
1157
9
.
9.
Sherr
JL
,
Schoelwer
M
,
Dos Santos
TJ
,
Reddy
L
,
Biester
T
,
Galderisi
A
, et al
.
ISPAD clinical practice consensus guidelines 2022: diabetes technologies: insulin delivery
.
Pediatr Diabetes
.
2022
;
23
(
8
):
1406
31
.
10.
Binder
E
,
Lange
O
,
Edlinger
M
,
Meraner
D
,
Abt
D
,
Moser
C
, et al
.
Frequency of dermatological side effects of continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes
.
Exp Clin Endocrinol Diabetes
.
2015
;
123
(
4
):
260
4
.
11.
Conwell
LS
,
Pope
E
,
Artiles
AM
,
Mohanta
A
,
Daneman
A
,
Daneman
D
.
Dermatological complications of continuous subcutaneous insulin infusion in children and adolescents
.
J Pediatr
.
2008
;
152
(
5
):
622
8
.
12.
Schober
E
,
Rami
B
.
Dermatological side effects and complications of continuous subcutaneous insulin infusion in preschool-age and school-age children
.
Pediatr Diabetes
.
2009
;
10
(
3
):
198
201
.
13.
Ross
P
,
Gray
AR
,
Milburn
J
,
Kumarasamy
IM
,
Wu
F
,
Farrand
S
, et al
.
Insulin pump-associated adverse events are common, but not associated with glycemic control, socio-economic status, or pump/infusion set type
.
Acta Diabetol
.
2016
;
53
(
6
):
991
8
.
14.
Berg
AK
,
Olsen
BS
,
Thyssen
JP
,
Zachariae
C
,
Simonsen
AB
,
Pilgaard
K
, et al
.
High frequencies of dermatological complications in children using insulin pumps or sensors
.
Pediatr Diabetes
.
2018
;
19
(
4
):
733
40
.
15.
Godoi
A
,
Reis Marques
I
,
Padrão
EMH
,
Mahesh
A
,
Hespanhol
LC
,
Riceto Loyola Júnior
JE
, et al
.
Glucose control and psychosocial outcomes with use of automated insulin delivery for 12 to 96 weeks in type 1 diabetes: a meta-analysis of randomised controlled trials
.
Diabetol Metab Syndr
.
2023
;
15
:
190
.
16.
Berg
A
,
Zachariae
C
,
Nørgaard
K
,
Svensson
J
.
Skin problems due to treatment with diabetes technology: a narrative review
.
Med Res Arch
.
2023
;
11
;(
11
). Available at: https://esmed.org/MRA/mra/article/view/4747
17.
Burgmann
J
,
Biester
T
,
Grothaus
J
,
Kordonouri
O
,
Ott
H
.
Pediatric diabetes and skin disease (PeDiSkin): a cross-sectional study in 369 children, adolescents and young adults with type 1 diabetes
.
Pediatr Diabetes
.
2020
;
21
(
8
):
1556
65
.
18.
Passanisi
S
,
Galletta
F
,
Bombaci
B
,
Cherubini
V
,
Tiberi
V
,
Minuto
N
, et al
.
Device-related skin reactions increase emotional burden in youths with type 1 diabetes and their parents
.
J Diabetes Sci Technol
.
2024
:
19322968241253285
.
19.
Asarani
NAM
,
Reynolds
AN
,
Boucher
SE
,
de Bock
M
,
Wheeler
BJ
.
Cutaneous complications with continuous or flash glucose monitoring use: systematic review of trials and observational studies
.
J Diabetes Sci Technol
.
2020
;
14
(
2
):
328
37
.
20.
Rigo
RS
,
Levin
LE
,
Belsito
DV
,
Garzon
MC
,
Gandica
R
,
Williams
KM
.
Cutaneous reactions to continuous glucose monitoring and continuous subcutaneous insulin infusion devices in type 1 diabetes mellitus
.
J Diabetes Sci Technol
.
2020
:
1932296820918894
.
21.
Petrovski
G
,
Campbell
J
,
Pasha
M
,
Hussain
K
,
Khalifa
A
,
Umer
F
, et al
.
Twelve-month follow-up from a randomized controlled trial of simplified meal announcement versus precise carbohydrate counting in adolescents with type 1 diabetes using the MiniMedTM 780G advanced hybrid closed-loop system
.
Diabetes Technol Ther
.
2024
;
26
(
S3
):
76
83
.
22.
Lakshman
R
,
Hartnell
S
,
Ware
J
,
Allen
JM
,
Wilinska
ME
,
Nwokolo
M
, et al
.
Lived experience of fully closed-loop insulin delivery in adults with type 1 diabetes
.
Diabetes Technol Ther
.
2024
;
26
(
4
):
211
21
.
23.
Passanisi
S
,
Berg
AK
,
Chobot
A
,
Dos Santos
TJ
,
Piona
CA
,
Messer
L
, et al
.
First international survey on diabetes providers’ assessment of skin reactions in youth with type 1 diabetes using technological devices
.
J Diabetes Sci Technol
.
2023
:
19322968231206155
.
24.
Harris
PA
,
Taylor
R
,
Thielke
R
,
Payne
J
,
Gonzalez
N
,
Conde
JG
.
Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support
.
J Biomed Inform
.
2009
;
42
(
2
):
377
81
.
25.
Harris
PA
,
Taylor
R
,
Minor
BL
,
Elliott
V
,
Fernandez
M
,
O’Neal
L
, et al
.
The REDCap consortium: building an international community of software platform partners
.
J Biomed Inform
.
2019
;
95
:
103208
.
26.
Fitzpatrick
TB
.
The validity and practicality of sun-reactive skin types I through VI
.
Arch Dermatol
.
1988
;
124
(
6
):
869
71
.
27.
Weinstock
MA
.
Assessment of sun sensitivity by questionnaire: validity of items and formulation of a prediction rule
.
J Clin Epidemiol
.
1992
;
45
(
5
):
547
52
.
28.
Cao
J
,
Zhang
S
.
Multiple comparison procedures
.
JAMA
.
2014
;
312
(
5
):
543
4
.
29.
McNichol
L
,
Lund
C
,
Rosen
T
,
Gray
M
.
Medical adhesives and patient safety: state of the science: consensus statements for the assessment, prevention, and treatment of adhesive-related skin injuries
.
J Wound Ostomy Continence Nurs
.
2013
;
40
(
4
):
365
80
.
30.
Berg
AK
,
Grauslund
AC
,
Sørensen
F
,
Thorsen
SU
,
Thyssen
JP
,
Zachariae
C
, et al
.
A skin care program to prevent skin problems due to diabetes devices in children and adolescents: a cluster-controlled intervention study
.
Diabetes Care
.
2023
;
46
(
10
):
1770
7
.
31.
Gentile
S
,
Strollo
F
,
Ceriello
A
,
AMD-OSDI Injection Technique Study Group
,
Botta
A
,
Cucco
L
.
Lipodystrophy in insulin-treated subjects and other injection-site skin reactions: are we sure everything is clear
.
Diabetes Ther
.
2016
;
7
(
3
):
401
9
.
32.
Genève
P
,
Adam
T
,
Delawoevre
A
,
Jellimann
S
,
Legagneur
C
,
DiPatrizio
M
, et al
.
High incidence of skin reactions secondary to the use of adhesives in glucose sensors or insulin pumps for the treatment of children with type 1 diabetes
.
Diabetes Res Clin Pract
.
2023
;
204
:
110922
.
33.
Patel
B
,
Priefer
R
.
Infections associated with diabetic-care devices
.
Diabetes Metab Syndr
.
2021
;
15
(
2
):
519
24
.
34.
Chen
X
,
Wu
X
,
Yuan
T
,
Guan
L
,
Guo
Q
,
Zheng
Y
, et al
.
Prevalence of skin problems caused by insulin pump therapy and associated factors in children with type 1 diabetes mellitus: a large cross-sectional survey in China
.
Diabetes Res Clin Pract
.
2024
;
212
:
111714
.
35.
Fröhlich-Reiterer
E
,
Elbarbary
NS
,
Simmons
K
,
Buckingham
B
,
Humayun
KN
,
Johannsen
J
, et al
.
ISPAD Clinical Practice Consensus Guidelines 2022: other complications and associated conditions in children and adolescents with type 1 diabetes
.
Pediatr Diabetes
.
2022
;
23
(
8
):
1451
67
.
36.
Pavlovic
MD
,
Milenkovic
T
,
Dinic
M
,
Misovic
M
,
Dakovic
D
,
Todorovic
S
, et al
.
The prevalence of cutaneous manifestations in young patients with type 1 diabetes
.
Diabetes Care
.
2007
;
30
(
8
):
1964
7
.
37.
Yosipovitch
G
,
Hodak
E
,
Vardi
P
,
Shraga
I
,
Karp
M
,
Sprecher
E
, et al
.
The prevalence of cutaneous manifestations in IDDM patients and their association with diabetes risk factors and microvascular complications
.
Diabetes Care
.
1998
;
21
(
4
):
506
9
.
38.
Berg
AK
,
Grauslund
AC
,
Nørgaard
K
,
Thorsen
SU
,
Zachariae
C
,
Halling
AS
, et al
.
Similar skin barrier function in persons with type 1 diabetes compared with healthy controls
.
JID Innov
.
2023
;
3
(
4
):
100200
.
39.
Bourgeois
J
,
Beer
J
,
Jacob
L
,
Henry
M
.
Scarring and dyschromias in Fitzpatrick skin type IV-VI: a review of dermatologic treatment protocols
.
J Drugs Dermatol
.
2023
;
22
(
3
):
288
96
.
40.
Herman
A
,
Uter
W
,
Rustemeyer
T
,
Matura
M
,
Aalto-Korte
K
,
Duus Johansen
J
, et al
.
Position statement: the need for EU legislation to require disclosure and labelling of the composition of medical devices
.
J Eur Acad Dermatol Venereol
.
2021
;
35
(
7
):
1444
8
.
41.
Paret
M
,
Barash
G
,
Rachmiel
M
.
“Out of the box” solution for skin problems due to glucose-monitoring technology in youth with type 1 diabetes: real-life experience with fluticasone spray
.
Acta Diabetol
.
2020
;
57
(
4
):
419
24
.
42.
Aschoff
R
,
Schmitt
J
,
Knuschke
P
,
Koch
E
,
Bräutigam
M
,
Meurer
M
.
Evaluation of the atrophogenic potential of hydrocortisone 1% cream and pimecrolimus 1% cream in uninvolved forehead skin of patients with atopic dermatitis using optical coherence tomography
.
Exp Dermatol
.
2011
;
20
(
10
):
832
6
.
43.
Freckmann
G
,
Buck
S
,
Waldenmaier
D
,
Zschornack
E
,
Link
M
,
Jendrike
N
, et al
.
Skin reaction report form: development and design of a standardized report form for skin reactions due to medical devices for diabetes management
.
J Diabetes Sci Technol
.
2020
:
1932296820911105
.
44.
Novak-Bilić
G
,
Vučić
M
,
Japundžić
I
,
Meštrović-Štefekov
J
,
Stanić-Duktaj
S
,
Lugović-Mihić
L
.
Irritant and allergic contact dermatitis - skin lesion characteristics
.
Acta Clin Croat
.
2018
;
57
(
4
):
713
20
.
45.
Berg
AK
,
Thorsen
SU
,
Thyssen
JP
,
Zachariae
C
,
Keiding
H
,
Svensson
J
.
Cost of treating skin problems in patients with diabetes who use insulin pumps and/or glucose sensors
.
Diabetes Technol Ther
.
2020
;
22
(
9
):
658
65
.
46.
Lombardo
F
,
Bombaci
B
,
Alibrandi
A
,
Visalli
G
,
Salzano
G
,
Passanisi
S
.
The impact of insulin-induced lipodystrophy on glycemic variability in pediatric patients with type 1 diabetes
.
Children (Basel)
.
2022
;
9
(
7
):
1087
.
47.
Tian
T
,
Aaron
RE
,
Huang
J
,
Yeung
AM
,
Svensson
J
,
Gentile
S
, et al
.
Lipohypertrophy and insulin: an update from the diabetes technology society
.
J Diabetes Sci Technol
.
2023
:
19322968231187661
.
48.
DeSalvo
DJ
,
Maahs
DM
,
Messer
L
,
Wadwa
RP
,
Payne
S
,
Ly
TT
, et al
.
Effect of lipohypertrophy on accuracy of continuous glucose monitoring in patients with type 1 diabetes
.
Diabetes Care
.
2015
;
38
(
10
):
e166
167
.
49.
Passanisi
S
,
Salzano
G
,
Lombardo
F
.
Skin involvement in paediatric patients with type 1 diabetes
.
Curr Diabetes Rev
.
2022
;
18
(
4
):
e030921196145
55
.
50.
Jedlowski
PM
,
Te
CH
,
Segal
RJ
,
Fazel
MT
.
Cutaneous adverse effects of diabetes mellitus medications and medical devices: a review
.
Am J Clin Dermatol
. 2018;
20
(
1
):
97
114
.
You do not currently have access to this content.